therapeutic antibody

MAB Discovery technology is to be used for the selection and development of therapeutic antibodies against drug-resistant Klebsiella pneumoniae as part of the SPARKLE Consortium, it has been announced. Read more


A strategic partnership has been formed between scientists from Emulate and Roche (F Hoffman La-Roche) for the application of organ-chips in the testing of the efficacy and safety of new antibody therapeutics and combination therapies. Read more


A collaboration has been initiated between Cullinan Oncology and MAB Discovery that is focused on the development of novel antibody-based therapeutics. Read more


BioCellChallenge has announced its positive results from in-vivo tests of a therapeutic antibody Read more